FindTrial
Sign In

A Pilot Study Exploring the Biomarkers of Sepsis-Associated Encephalopathy (SAE)

A Pilot Study Exploring the Biomarkers of Sepsis-Associated Encephalopathy (SAE) Metabolomics Evidence - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/06/088310
Enrollment
30
Registered
2025-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G988- Other disorders of nervous system

Interventions

Intervention1: Nil: Nil

Sponsors

Indira Gandhi Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sepsis who meet at least 2 of these criteria Body temperature over 38 or under 36 degrees Celsius,Heart rate greater than 90 beats/minute,Respiratory rate greater than 20 breaths/minute or partial pressure of CO2 less than 32 mmHg,Leukocyte count greater than 12000 or less than 4000 /microliters or over 10% immature forms or bands.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To assess the levels of metabolic proteins in CSF and peripheral blood of patients with SepsisTimepoint: Baseline—

Secondary

MeasureTime frame
To analyse composition of proteins To establish a correlation between blood metabolites & csf metabolites Timepoint: Baseline—

Countries

India

Contacts

Public ContactRitu Singh

Indira Gandhi Institute of Medical Sciences

ritusingh140@gmail.com8127395753

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026